Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation.
Schlemmer
F
F
Lagrange-Xélot
M
M
Lacroix
C
C
de La Tour
R
R
Socié
G
G
Molina
J-M
JM
D000935:Antifungal Agents / Q000008:administration & dosage*; D006801:Humans; D008224:Lymphoma, Follicular / Q000382:microbiology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009091:Mucormycosis / Q000382:microbiology / Q000517:prevention & control*; D012220:Rhinitis / Q000382:microbiology / Q000517:prevention & control; D012233:Rhizopus; D012852:Sinusitis / Q000382:microbiology / Q000517:prevention & control; D033581:Stem Cell Transplantation; D013997:Time Factors; D014184:Transplantation, Homologous; D014230:Triazoles / Q000008:administration & dosage*
D000935:Antifungal Agents; D014230:Triazoles; C101425:posaconazole